Voice-Activated Technology to Improve Mobility in Multimorbid, Frail, Homebound Older Adults (EngAGE)
NCT ID: NCT05337514
Last Updated: 2026-02-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
137 participants
INTERVENTIONAL
2022-10-26
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
engAGE: Managing cognitivE decliNe throuGh Theatre Therapy, Artificial Intelligence and Social Robots drivEn Interventions
NCT06302686
Enhancing Quality of Life for Older Adults With and Without Mild Cognitive Impairment (MCI) Through Social Engagement Over Video Technology
NCT05380180
Experimental Control Investigation of the Impact of Assistive Technology on the User-caregiver Dyad: a Multi-site Trial
NCT00927706
City For All Ages: Elderly-friendly City Services for Active and Healthy Ageing
NCT06486935
FrAilty Care and wEll-funcTion in Community Dwelling Older Adults
NCT03707145
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All OA subjects will undergo an in-home baseline visit where we will collect data about physical function, social function, activity and frailty. OA-CP dyads will be randomized (1:1) to a physical activity intervention: either EngAGE or usual care. All subjects will be asked to complete exercises 3-6 times per week. Care Partners will be instructed to encourage their Older Adult partner to perform physical activities on a regular basis. There is a two week Run-In Period to troubleshoot the EngAGE app and acclimate the OA subjects to the study intervention. OA subjects will be monitored via phone visits on a monthly basis. In home study visits will take place at month 3 and month 6. Data about OA subject physical function, social function, activity and frailty will be collected at these visits.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
EngAGE
Older adult subjects will receive an Alexa Echo Show that runs an exercise app called EngAGE.
Enhanced Engagement
EngAGE will allow care partners send older adults encouragement which will be read aloud to the older adult through the EngAGE app.
Physical Exercise Handouts
Older adults subjects will receive a paper booklet containing exercise instructions.
Standard Engagement
Care partners can encourage their older adult partner using traditional / existing communication mechanisms.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Enhanced Engagement
EngAGE will allow care partners send older adults encouragement which will be read aloud to the older adult through the EngAGE app.
Standard Engagement
Care partners can encourage their older adult partner using traditional / existing communication mechanisms.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* has at least 2 chronic conditions
* requires any assistance to leave the home (this may include requiring someone to drive, requiring the use of a cane or walker, or similar)
* can read 14 point font from a 2-foot distance on a tablet-sized screen
* can hear spoken voice from 2-foot distance
* SPPB score of less than or equal to 9 but greater than 3 on a 12-point scale to target moderate but not severe functional impairment.
Exclusion Criteria
* inability to stand unassisted;
* inability to understand English (because the intervention is currently only available in English);
* life expectancy less than 12 months or enrolled in Hospice;
* a medical condition making unsupervised physical activity potentially unsafe including: stroke within prior 12 months, acute myocardial infarction or unstable angina in the prior 6 months, uncontrolled arrhythmias, dissecting aortic aneurysm, acute endo/pericarditis, acute thromboembolism, acute or severe heart or respiratory failure, uncontrolled hypertension greater than 180/100, fracture or joint replacement within the prior 3 months, infections affecting one's general health condition, severe peripheral vascular disease.
* severe functional impairment as indicated by an SPPB score less than 3 (out of 12);
* baseline Montreal Cognitive Assessment of less than or equal to 18/30;
* inability to understand consent (teach back).
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rush University
OTHER
National Opinion Research Center
OTHER
National Institute on Minority Health and Health Disparities (NIMHD)
NIH
University of Chicago
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Megan Huisingh-Scheetz, MD
Role: PRINCIPAL_INVESTIGATOR
University of Chicago
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Chicago
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB21-1556
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.